Phase II Trial of Lenvatinib-Pembrolizumab Maintenance Therapy in Patients With Advanced Unresectable Pancreatic Cancer
The purpose of this phase II study is to evaluate the safety and efficacy of Lenvatinib and pembrolizumab as maintenance therapy in patients with pancreatic cancer.
Study ID: 21092
Trial Phase: Phase II
Trial Sponsor: City of Hope
Therapies Used in This Trial: Pembrolizumab, Lenvatinib